biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Post by Sniper007on Apr 17, 2014 4:27pm

199 Views

Post# 22465397

Irked

It irks me beyond belief the sp of BTI is at $1.05. What a joke. Even preclinical, this stock should be WAY more than it is, especially given the opportunity these pharmaceutical companies have to potentially extent their patent lives for decades to come. That alone is worth billions…and that’s a fact Jack! BTI needs to do a better job of marketing on each and every opportunity they have and do it more often. BTI needs to blow their horn with conviction.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario